New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells

Memory T-cells, particularly, effector memory T cells are implicated in the pathogenesis of inflammatory diseases and may contribute to tissue injury and disease progression. Although erythema nodosum leprosum (ENL) is an inflammatory complication of leprosy, the role of memory T cell subsets has never been studied in this patient group. The aim of this study was at investigate the kinetics of memory T cell subsets in patients with ENL before and after prednisolone treatment. A case–control study design was used to recruit 35 untreated patients with ENL and 25 non-reactional lepromatous leprosy (LL) patient controls at ALERT Hospital, Ethiopia. Venous blood samples were obtained before, during, and after treatment from each patient. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of T cell activation and memory T-cell subsets by flow cytometry. The kinetics of these immune cells in patients with ENL before and after treatment were compared with LL patient controls as well as within ENL cases at different time points. The median percentage of CD3+, CD4+, and CD8+ T-cells expressing activated T-cells were significantly higher in the PBMCs from patients with ENL than from LL patient controls before treatment. The median percentage of central and activated memory T-cells was significantly increased in patients with ENL compared to LL patient controls before treatment. Interestingly, patients with ENL had a lower percentage of naïve T cells (27.7%) compared to LL patient controls (59.5%) (P < 0.0001) before treatment. However, after prednisolone treatment, patients with ENL had a higher median percentage of naïve T-cells (43.0%) than LL controls (33.0%) (P < 0.001). The median percentage of activated T-cells (effector memory and effector T-cells) was significantly increased in patients with ENL (59.2%) before treatment compared to after treatment with prednisolone (33.9%) (P < 0.005). This is the first work which has shown T-cell activation and the different subsets of memory T cells in untreated patients with ENL. Consequently, this study delineates the role of T-cell activation in the pathogenesis of ENL reaction and challenges the long-standing dogma of immune complex as a sole etiology of ENL reaction.

[1]  E. Sarno,et al.  Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients , 2016, PloS one.

[2]  V. Golubovskaya,et al.  Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy , 2016, Cancers.

[3]  L. Dölken,et al.  Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial , 2016, PloS one.

[4]  Y. Ogawa,et al.  Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging , 2015, Cancers.

[5]  T. Kupper,et al.  The emerging role of resident memory T cells in protective immunity and inflammatory disease , 2015, Nature Medicine.

[6]  E. Sarno,et al.  Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse , 2015, PloS one.

[7]  Maria L. Thompson,et al.  Cryopreservation and Thawing of Mammalian Cells , 2014 .

[8]  J. Flynn,et al.  Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies , 2014, Clinical & translational immunology.

[9]  T. Ottenhoff,et al.  T-Cell Regulation in Lepromatous Leprosy , 2014, PLoS neglected tropical diseases.

[10]  D. Lockwood,et al.  The Mortality Associated with Erythema Nodosum Leprosum in Ethiopia: A Retrospective Hospital-Based Study , 2014, PLoS neglected tropical diseases.

[11]  S. Howie,et al.  Effector and central memory T helper 2 cells respond differently to peptide immunotherapy , 2014, Proceedings of the National Academy of Sciences.

[12]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[13]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[14]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[15]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[16]  D. Lockwood,et al.  Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. , 2006, The American journal of tropical medicine and hygiene.

[17]  K. Ley,et al.  L-selectin in inflammation, infection and immunity , 2005 .

[18]  S. Ehlers.  Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[20]  JoAnne L. Flynn,et al.  Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.

[21]  Shlomo S. Sawilowsky,et al.  Review of Twenty Nonparametric Statistics and Their Large Sample Approximations. , 2000 .

[22]  M. Roederer,et al.  Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. , 1999, International immunology.

[23]  D. Lockwood,et al.  Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. , 1993, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[24]  Gilla Kaplan,et al.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization , 1989, The Journal of experimental medicine.

[25]  B. Hepburn,et al.  Effect of divided daily dose prednisone therapy on circulating T cell subsets. , 1987, The Journal of rheumatology.

[26]  R. Steinman,et al.  An analysis of in vitro T cell responsiveness in lepromatous leprosy , 1985, The Journal of experimental medicine.

[27]  D. Ridley,et al.  The immunopathology of erythema nodosum leprosum: the role of extravascular complexes. , 1983, Leprosy review.

[28]  D. Ridley,et al.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. , 1973, Clinical and experimental immunology.

[29]  S. Frøland,et al.  Evidence that the Mechanism of Immunological Tolerance (‘Central Failure’) Is Operative in the Lack of Host Resistance in Lepromatous Leprosy , 1972, Scandinavian journal of immunology.

[30]  T. Godal,et al.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. , 1971, Clinical and experimental immunology.

[31]  M. Baniyash.  TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. , 2004, Nature reviews. Immunology.

[32]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .